会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Gold nanoparticle based protease imaging probes and use thereof
    • 基于金纳米颗粒的蛋白酶成像探针及其用途
    • US08551727B2
    • 2013-10-08
    • US12595078
    • 2008-04-10
    • Ick-Chan KwonKui-Won ChoiKwang-Meyung KimCheol-Hee AhnIn-Chan YounSeul-Ki LeeKyeong-Soon Park
    • Ick-Chan KwonKui-Won ChoiKwang-Meyung KimCheol-Hee AhnIn-Chan YounSeul-Ki LeeKyeong-Soon Park
    • C12Q1/37C12Q1/34B82B3/00C12N11/14C12N11/18
    • A61K49/0056A61K49/0032A61K49/0065A61K49/0093C12Q1/37
    • Disclosed are a metal nanoparticle onto which a peptide substrate specifically degraded by protease and fluorophore are chemically modified for selectively imaging protease expressed in cell and in tissue in a human body, and the use thereof. Also, a quantitative analysis method of protease using the metal nanoparticle, a cell imaging method and a drug screening method of inhibiting a protease overexpression are provided. In detail, the present invention is directed to a metal nanoparticle having a peptide substrate and fluorophore coupled thereto, the peptide substrate and the fluorophore being specifically degraded by due to a protease activated in various ways in cell and in a human body to exhibit fluorescence. Hence, the metal nanoparticle can be used to rapidly screen activation and inhibition of the protease in the imaging manner. Also, the metal nanoparticle is capable of being selectively absorbed into a cell and a tissue so as to be possibly used as a sensor for real-time cell imaging and early diagnosis of non-invasive diseases.
    • 公开了一种金属纳米颗粒,其上通过蛋白酶和荧光团特异性降解的肽底物被化学修饰以选择性地成像在细胞和人体组织中表达的蛋白酶及其用途。 另外,提供了使用金属纳米粒子的蛋白酶的定量分析方法,细胞成像方法和抑制蛋白酶过表达的药物筛选方法。 详细地说,本发明涉及一种具有肽底物和与其连接的荧光团的金属纳米颗粒,肽底物和荧光团由于在细胞和人体中以各种方式活化的蛋白酶而被特异性地降解以显示出荧光。 因此,金属纳米颗粒可用于以成像方式快速筛选蛋白酶的活化和抑制。 此外,金属纳米粒子能够被选择性地吸收到细胞和组织中,以便可能用作用于实时细胞成像和非侵入性疾病的早期诊断的传感器。
    • 6. 发明申请
    • GOLD NANOPARTICLE BASED PROTEASE IMAGING PROBES AND USE THEREOF
    • 基于金纳米粒子的蛋白成像探针及其应用
    • US20100124757A1
    • 2010-05-20
    • US12595078
    • 2008-04-10
    • Ick-Chan KwonKui-Won ChoiKwang-Meyung KimCheol-Hee AhnIn-Chan YounSeul-Ki LeeKyeong-Soon Park
    • Ick-Chan KwonKui-Won ChoiKwang-Meyung KimCheol-Hee AhnIn-Chan YounSeul-Ki LeeKyeong-Soon Park
    • C12Q1/37C07K2/00
    • A61K49/0056A61K49/0032A61K49/0065A61K49/0093C12Q1/37
    • Disclosed are a metal nanoparticle onto which a peptide substrate specifically degraded by protease and fluorophore are chemically modified for selectively imaging protease expressed in cell and in tissue in a human body, and the use thereof. Also, a quantitative analysis method of protease using the metal nanoparticle, a cell imaging method and a drug screening method of inhibiting a protease overexpression are provided. In detail, the present invention is directed to a metal nanoparticle having a peptide substrate and fluorophore coupled thereto, the peptide substrate and the fluorophore being specifically degraded by due to a protease activated in various ways in cell and in a human body to exhibit fluorescence. Hence, the metal nanoparticle can be used to rapidly screen activation and inhibition of the protease in the imaging manner. Also, the metal nanoparticle is capable of being selectively absorbed into a cell and a tissue so as to be possibly used as a sensor for real-time cell imaging and early diagnosis of non-invasive diseases.
    • 公开了一种金属纳米颗粒,其上通过蛋白酶和荧光团特异性降解的肽底物被化学修饰以选择性地成像在细胞和人体组织中表达的蛋白酶及其用途。 另外,提供了使用金属纳米粒子的蛋白酶的定量分析方法,细胞成像方法和抑制蛋白酶过表达的药物筛选方法。 详细地说,本发明涉及一种具有肽底物和与其连接的荧光团的金属纳米颗粒,肽底物和荧光团由于在细胞和人体中以各种方式活化的蛋白酶而被特异性地降解以显示出荧光。 因此,金属纳米颗粒可用于以成像方式快速筛选蛋白酶的活化和抑制。 此外,金属纳米粒子能够被选择性地吸收到细胞和组织中,以便可能用作用于实时细胞成像和非侵入性疾病的早期诊断的传感器。
    • 7. 发明授权
    • Human serum albumin-siRNA nano-sized carrier system
    • 人血清白蛋白siRNA siRNA纳米载体体系
    • US08513402B2
    • 2013-08-20
    • US13245180
    • 2011-09-26
    • Kwangmeyung KimIck Chan KwonKuiwon ChoiIn Chan YounMyungSook HuhSojin Lee
    • Kwangmeyung KimIck Chan KwonKuiwon ChoiIn Chan YounMyungSook HuhSojin Lee
    • C07H21/04
    • C12N15/111A61K47/643C12N2320/32
    • Disclosed are a human serum albumin-siRNA carrier system having siRNA bound to human serum albumin and a user thereof, and especially, human serum albumin-siRNA carrier system, which has a biodegradable covalent bond between human serum albumin polymer and siRNA and is stable in a living body, and a user thereof.The human serum albumin-siRNA carrier system having the biodegradable covalent bond between the human serum albumin and the siRNA exhibits high siRNA delivery efficiency to a target site in the living body. Therefore, the human serum albumin-siRNA carrier system may allow siRNA for therapy to be efficiently delivered to a target site such as cancer tissues in the living body even by being administrated in a relatively low concentration, which may result in a wide use for therapies of various diseases.
    • 公开了具有与人血清白蛋白结合的siRNA及其使用者的人血清白蛋白-siRNA载体体系,特别是人血清白蛋白-siRNA载体体系,其在人血清白蛋白聚合物和siRNA之间具有可生物降解的共价键,并且在 生物体及其使用者。 在人体血清白蛋白和siRNA之间具有可生物降解的共价键的人血清白蛋白-siRNA载体体系对生物体中的靶位点显示出高的siRNA递送效率。 因此,人体血清白蛋白-siRNA载体体系可以使siRNA用于治疗有效地递送到目标部位如生物体中的癌组织,甚至通过以相对低的浓度施用,这可能导致广泛用于治疗 的各种疾病。